pembrolizumab
merck
['nsclc', 'sclc', 'confirm,(-confirma),(-confirme),(-confirmi)']
longer follow up confirms survival benefit of chemo-immunotherapy in nsclc. important update from #esmo22 by 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him